President Joe Biden doubled his COVID-19 vaccine goal from 100 million to 200 million doses administered within his first 100 days. The U.S. has already administered more than 133 million doses as of Thursday. (POLITICO)

Pfizer has started testing its COVID-19 vaccine in children younger than 12, with the trial results to be released later in the year. Moderna and AstraZeneca have also begun testing their vaccines in young children. (The New York Times)

Bristol Myers Squibb released topline data from a Phase III trial Thursday that shows promise for the LAG-3 class of checkpoint inhibitors in cancer treatment. The results showed a combination of antibody relatlimab and PD-1 inhibitor Opdivo extended progression-free survival in melanoma patients. (Endpoints News)

The risks of an experimental pain therapy from Pfizer may outweigh the benefits, according to expert advisers to the Food and Drug Administration. The injectable drug for osteoarthritis has been linked to cases of serious joint damage. (STAT)

Biden has devoted $10 billion to address racial inequities in vaccine distribution, drawing on funds from the American Rescue Plan. $6 billion of that money will be sent to 1,400 community health centers across the U.S. (The Philadelphia Inquirer)